SIGA Technologies Inc. (SIGA) financial statements (2020 and earlier)

Company profile

Business Address 31 EAST 62ND STREET
NEW YORK, NY 10065
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments65101202911310091
Cash and cash equivalents65101202911310091
Restricted cash and investments96111110   
Receivables4223401
Inventory, net of allowances, customer advances and progress billings103326121921
Inventory103326121921
Other undisclosed current assets542111111
Total current assets:1801213769129130124
Noncurrent Assets
Property, plant and equipment3000011
Intangible assets, net (including goodwill)1111111
Goodwill1111111
Restricted cash and investments 68717 4 
Deferred costs  9773533323
Other noncurrent assets1111222
Deferred tax assets, net122    
Other undisclosed noncurrent assets14    (4)43
Total noncurrent assets:198210792563770
TOTAL ASSETS:199203145161186166194
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1211777610
Accounts payable3213435
Accrued liabilities91055325
Employee-related liabilities     0 
Debt80    22
Other undisclosed current liabilities   7 (0)0
Total current liabilities:92117147712
Noncurrent Liabilities
Long-term debt and lease obligation      2
Long-term debt, excluding current maturities      2
Liabilities, other than long-term debt  3783682566162
Deferred revenue and credits3783672550162
Deferred tax liabilities, net  006 
Other undisclosed noncurrent liabilities98983672073990
Total noncurrent liabilities:989461435463405165
Total liabilities:101101468448470413177
Stockholders' equity
Stockholders' equity attributable to parent98103(323)(287)(284)(247)17
Common stock0000000
Additional paid in capital221219214214177175173
Accumulated deficit(123)(116)(537)(501)(461)(422)(157)
Total stockholders' equity:98103(323)(287)(284)(247)17
TOTAL LIABILITIES AND EQUITY:199203145161186166194

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues27477     
Cost of revenue(2)(95)(1)    
Cost of goods and services sold  (1)    
Gross profit:25382(1)    
Operating expenses(29)(122)(31)(46)(39)(213)(29)
Other undisclosed operating income2951315836
Operating income (loss):(2)355(19)(31)(31)(210)(24)
Nonoperating income37900000
Interest and debt expense(16)(15)(15)(2)(0)(0)(1)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes5(7)(5)(6)(8)(2)(0)
Income (loss) from continuing operations before income taxes:(10)412(38)(40)(39)(212)(25)
Income tax expense (benefit)3102(0)(0)(54)8
Net income (loss) available to common stockholders, diluted:(7)422(36)(40)(39)(265)(17)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(7)422(36)(40)(39)(265)(17)
Comprehensive income (loss), net of tax, attributable to parent:(7)422(36)(40)(39)(265)(17)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: